Skip to main content

AbbVie Inc. gross profit

  • ABBV · NYSE
  • Pharmaceuticals
  • Biotechnology
  • S&P 500
$295.03+0.20%Close 13 Nov 2026 · Market value $524.5B

AbbVie Inc.'s gross profit was $43.0 billion for fiscal year 2025 (the twelve months to 31 Dec 2025), up 8.9% from fiscal 2024.

In the third quarter of fiscal 2026 (the three months to 30 Sep 2026) it was $13.1 billion, up 25.3% from a year earlier.

Over the four quarters to 30 Sep 2026, gross profit was $48.7 billion.

From AbbVie Inc.'s annual and quarterly reports, compiled and checked by AapWire. Latest report filed 3 Nov 2026.

Fiscal 2025
$43.0B
+8.9%
Q3 FY2026
$13.1B
+25.3% on a year
Growth over 9 years
+9.0%
a year, FY 2016–FY 2025

Gross profit by fiscal year

$19.8BFY 2016$21.2BFY 2017+6.9%$25.0BFY 2018+18.2%$25.8BFY 2019+3.2%$30.4BFY 2020+17.8%$38.8BFY 2021+27.4%$40.6BFY 2022+4.9%$33.9BFY 2023−16.6%$39.4BFY 2024+16.3%$43.0BFY 2025+8.9%

Change on the year before, under each year. From FY 2016 to FY 2025, AbbVie Inc.'s gross profit went from $19.8 billion to $43.0 billion, a compound annual change of +9.0%; FY 2025 is the highest of the period.

AbbVie Inc. gross profit, fiscal years
PeriodFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Gross profit$19.8B$21.2B$25.0B$25.8B$30.4B$38.8B$40.6B$33.9B$39.4B$43.0B
Period end31 Dec 201631 Dec 201731 Dec 201831 Dec 201931 Dec 202031 Dec 202131 Dec 202231 Dec 202331 Dec 202431 Dec 2025

Gross profit by quarter

The last eight fiscal quarters. Each is compared with the same quarter a year earlier on the company's page.

AbbVie Inc. gross profit, fiscal quarters
PeriodQ4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Gross profit$10.7B$9.34B$11.1B$10.5B$12.1B$10.8B$12.7B$13.1B
Period end31 Dec 202431 Mar 202530 Jun 202530 Sep 202531 Dec 202531 Mar 202630 Jun 202630 Sep 2026

How gross profit is measured

Gross profit is revenue less the cost of the goods and services sold. Figures are read from the report the company filed and checked against accounting identities; one that does not pass is left blank rather than estimated. See data and methodology.

AbbVie Inc.'s other figures

Gross profit of comparable companies

Everything on ABBV, in the terminal.

Twenty years of history, operating KPIs and segments, guidance against results, valuation, insiders and holders, charts and alerts.